Excision Biotherapeutics Inc
Excision Biotherapeutics Inc, founded in 2015, is a biotechnology company based in San Francisco, CA, focused on developing CRISPR-based therapies aimed at curing viral infectious diseases. The company leverages proprietary gene-editing technology and collaborates with leading research institutions to create transformative therapies for patients suffering from chronic viral illnesses.
With multiple therapies in development targeting diseases such as HIV, herpes simplex viruses, and hepatitis B, Excision is at the forefront of innovative treatments. The company's mission is to improve the lives of patients living with these conditions, driven by a team of dedicated experts committed to advancing the field of gene editing.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.